Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can present as an
isolated skin disease or as a manifestation within the spectrum of systemic lupus …

Lupus erythematosus (LE) is a chronic, autoimmune, multisystem disease that displays
many diverse symptoms in which localized cutaneous LE (CLE) is on one end of the …

Please cite this paper as: Tyrosine kinase 2 and interferon regulatory factor 5
polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus …

Mycophenolate mofetil (MMF) is a new immunosuppressant recently introduced in the
treatment of autoimmune conditions. The greatest experience with the use of MMF has been …

Dapsone (DAP) is a long-established molecule that remains a promising therapeutic agent
for various diseases mainly because it combines antimicrobial and anti-inflammatory …

Background Lupus erythematosus (LE) is a heterogeneous disease ranging from mainly
skin-restricted manifestations (discoid LE [DLE] and subacute cutaneous LE) to a …

Introduction and objectives Lupus erythematosus is a chronic autoimmune inflammatory
disease with a wide clinical spectrum and variable clinical course. Few studies have …

A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
developed a Core Set Questionnaire for the evaluation of patients with cutaneous lupus …

Introducción y objetivos El lupus eritematoso es una enfermedad inflamatoria crónica
autoinmune con un amplio espectro clínico y evolutivo. Existen pocos estudios sobre las …

Abstract The 5th International Conference of Cutaneous Lupus Erythematosus was held in
Tokyo, Japan on May 9 and 10, 2023. The latest topics on the pathogenesis, diagnosis …